The Insider: Community Edition - August 2023
Featured News
New deep tech startup creator Embark announces first cohort of entrepreneurs
The Embark Deep Tech Startup Creator at Venture Partners at CU ÌÇÐÄVlogÆƽâ°æ has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from CU ÌÇÐÄVlogÆƽâ°æ's research labs to bring them to market and unleash the full impact of CU ÌÇÐÄVlogÆƽâ°æ's research into the world.
CU ÌÇÐÄVlogÆƽâ°æ partners on CO-WY Engine named finalist in NSF Regional Innovation Competition
Innosphere Ventures—CU ÌÇÐÄVlogÆƽâ°æ is one of the partner universities in the Colorado-Wyoming Engine proposal, a finalist in the National Science Foundation's (NSF) Regional Innovation Engines competition. The proposal aims to address climate solutions and community resiliency, competing for up to $160 million in funding over the next ten years.
CU ÌÇÐÄVlogÆƽâ°æ Startups and Innovations in the News
Meati Foods teams up with Whole Foods to launch its plant-based products nationwide
Denver Post—Meati Foods, a ÌÇÐÄVlogÆƽâ°æ-based producer of plant-based meat alternatives and CU ÌÇÐÄVlogÆƽâ°æ spinout, is expanding its commercial reach by selling to Whole Foods Markets across the country.
Physicist-turned-engineer earns international recognition for quantum contributions
College of Engineering and Applied Science—Svenja Knappe and her colleagues have developed a helmet that contains 128 sensors and is customizable for different sizes of the human head. Knappe founded the ÌÇÐÄVlogÆƽâ°æ-based company FieldLine and has begun to bring these sensors to market. In the not-so-distant future, they could aid in the diagnosis and treatment of a wide range of neurological conditions like epilepsy, autism and traumatic brain injuries.
VitriVax wins $29M Department of Defense contract for vaccine research
BizWest—VitriVax Inc., a ÌÇÐÄVlogÆƽâ°æ-based developer of vaccine-shot technology and CU ÌÇÐÄVlogÆƽâ°æ spinout, was recently awarded a five-year, $29 million contract from the U.S. Department of Defense to create a single-injection, thermostable vaccine for melioidosis and glanders.
New Iridium secures $1M NSF SBIR Phase II grant
Innosphere Ventures—New Iridium, a CU ÌÇÐÄVlogÆƽâ°æ spinoutÌýdedicated to decarbonizing the chemical industry and driving sustainable innovation, announced it has been awarded a $1 million National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant.ÌýThis grant will enable New Iridium to advance its cutting-edge photocatalysis platform that uses light rather than heat, revolutionizing the production of low-carbon chemicals while significantly reducing costs compared to today’s processes.
When it comes to treating resistant breast cancer, 2 drugs may be better than 1
CU ÌÇÐÄVlogÆƽâ°æ Today—In 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.